XPRSTREPA-CE-10
Delivers accurate and timely results that optimize fast treatment decisions
XPRSTREPA-CE-10
Delivers accurate and timely results that optimize fast treatment decisions
XP3SARS-COV2-10
Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2
XPRSARS-COV2-10
A near-patient test for the detection of the novel coronavirus that causes COVID-19.
XPRSFLU/RSV-CE-10
Accurate and reliable detection of Flu A, Flu B and RSV to quickly deliver targeted therapies.
XP3COV2/FLU/RSV-10
Actionable rapid respiratory results to meet the challenges of co-circulating respiratory viruses
GXSACOMP-CE-10
Detection of S. aureus and MRSA in about 65 minutes
GXMRSA/SA-SSTI-CE
Detect MRSA & SA Skin and Soft Tissue Infections in 62 minutes
GXCDIFFBT-CE-10
Detection of Clostridioides difficile infection with an independent call-out of binary toxin and differentiation of the 027 strain in around 45 minutes
GXNOV-CE-10
Fast detection of Norovirus GI & GII with results available in 90 minutes
GXMRSA/SABC-CE-10
MRSA and S. aureus detection from gram-positive blood culture samples in 62 minutes
GXVANA/B-CE-10
Rapid VRE screening for active prevention, control, and outbreak management in around 48 minutes
GXMRSA-NXG-CE-10
Active MRSA Surveillance testing in around 70 minutes
GXCARBARP-CE-10
Detection and differentiation of KPC, NDM, VIM, IMP-1, and OXA-48 in 50 minutes
GXHBV-VL-CE-10
Quantitation of Hepatitis B Virus (HBV) in less than one hour
S2A-95004
M. genitalium+ macrolide resistance detection
XPRSGBS-CE-10
Qualitative real-time PCR test providing accurate intrapartum detection of Group B Streptococcus in Labor/delivery
GXCT/NGX-CE-10
90-minute detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
GXHIV-QA-XC-CE-10
A molecular point-of-care test that delivers results in around 90 minutes
GXGBSLBXC-10
Detection of Group B Streptococcus with dual target with results within one hour
GXHCV-FS-CE-10
Detection and quantification of Hepatitis C virus (HCV) in about an hour
GXHIV-VL-XC-CE-10
Next Generation Molecular Testing for Monitoring Viral Load and HIV-1 Infection
GXTV-CE-10
Fast molecular detection of Trichomonas vaginalis for both women and men.
GXHPV2-CE-10
Reliable Detection of high-risk HPV DNA with Genotyping of HPV 16 and 18/45
GXHCV-VL-CE-10
Highly sensitive, timely results to support patient management
GXHCV-SPAK
Point-of-care hepatitis C RNA test that enables same-day linkage to care
GXMTB/XDR-10
Simplifying TB drug susceptibility testing utilizing increased multiplexing capability with 10 color GeneXpert® technology
GXMTB/RIF-ULTRA-50
Detection of Mycobacterium tuberculosis complex and Rifampin-resistance associated mutations in less than 80 minutes
GXBLAD-CM-CE-10
Qualitative monitoring for recurrence in patients previously diagnosed with bladder cancer in around 90 minutes
GXFIIFV-10
30-Minute Test for Genetic Risk of Thrombosis
GXBCSTRAT4-CE-10
Standardized breast cancer ESR1/PGR/ERBB2/MKi67 mRNA biomarker assessment in less than two hours
GXBLAD-CD-CE-10
Detection of the presence of bladder cancer in patients with hematuria in around 90 minutes
GXBCRABL-10
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
Available in 4, 16, 48, or 80-module configurations, each system has Cepheid’s proven GeneXpert® module at its analytic core and uses our patented cartridge technology for every Xpert® test. The platform is standardized yet scalable across the healthcare continuum — from hospital labs to emergency departments and decentralised settings.
Article
4m Read
May 19, 2025
RESPIRATORY HEALTH
Expert Perspective
5m Read
May 14, 2025
COMMUNITY AND GLOBAL HEALTH
View our additional portals to find documents and resources not listed here.
View our self-help articles, create a case, or view contact information.